白血病·淋巴瘤
白血病·淋巴瘤
백혈병·림파류
Journal of Leukemia & Lymphoma
2015年
8期
457-459,463
,共4页
吕瑞%邱录贵%徐燕%李健%李增军
呂瑞%邱錄貴%徐燕%李健%李增軍
려서%구록귀%서연%리건%리증군
外周T细胞淋巴瘤,非特指型%淋巴瘤,大细胞,弥漫型%EB病毒
外週T細胞淋巴瘤,非特指型%淋巴瘤,大細胞,瀰漫型%EB病毒
외주T세포림파류,비특지형%림파류,대세포,미만형%EB병독
Peripheral T-cell lymphoma,not otherwise specified%Lymphoma,large cell,diffuse%EB virus
目的 探讨外周T细胞淋巴瘤(PTCL)继发弥漫大B细胞淋巴瘤(DLBCL)的诊治方法.方法 报道1例PTCL继发DLBCL病例的诊治经过,分析该例患者的临床特点、治疗反应,复习文献探讨该类疾病的机制及预后.结果 患者诊断PTCL非特指型(PTCL-NOS)明确,治疗后出现以EB病毒(EBV)阴性DLBCL为表现的第二肿瘤,其临床特点及发病间隔与之前国外报道类似,可能涉及肿瘤细胞、微环境及治疗等多方面因素.该例患者初步治疗有效,有待进一步随访观察.结论 PTCL-NOS继发EBV阴性DLBCL非常罕见,发病机制和治疗效果有待进一步探索.
目的 探討外週T細胞淋巴瘤(PTCL)繼髮瀰漫大B細胞淋巴瘤(DLBCL)的診治方法.方法 報道1例PTCL繼髮DLBCL病例的診治經過,分析該例患者的臨床特點、治療反應,複習文獻探討該類疾病的機製及預後.結果 患者診斷PTCL非特指型(PTCL-NOS)明確,治療後齣現以EB病毒(EBV)陰性DLBCL為錶現的第二腫瘤,其臨床特點及髮病間隔與之前國外報道類似,可能涉及腫瘤細胞、微環境及治療等多方麵因素.該例患者初步治療有效,有待進一步隨訪觀察.結論 PTCL-NOS繼髮EBV陰性DLBCL非常罕見,髮病機製和治療效果有待進一步探索.
목적 탐토외주T세포림파류(PTCL)계발미만대B세포림파류(DLBCL)적진치방법.방법 보도1례PTCL계발DLBCL병례적진치경과,분석해례환자적림상특점、치료반응,복습문헌탐토해류질병적궤제급예후.결과 환자진단PTCL비특지형(PTCL-NOS)명학,치료후출현이EB병독(EBV)음성DLBCL위표현적제이종류,기림상특점급발병간격여지전국외보도유사,가능섭급종류세포、미배경급치료등다방면인소.해례환자초보치료유효,유대진일보수방관찰.결론 PTCL-NOS계발EBV음성DLBCL비상한견,발병궤제화치료효과유대진일보탐색.
Objective To investigate the diagnosis and treatment of sequential diffuse large B-cell lymphoma (DLBCL) after peripheral T-cell lymphoma (PTCL).Methods A case with sequential DLBCL after PTCL was reported,and the characteristics and responses of this case were analyzed.The previous literature was reviewed in order to explain the mechanism and prognosis of such type of disease.Results This patient was diagnosed as PTCL not otherwise specified (PTCL-NOS) definitely,but after a period of treatment,DLBCL was developed as a second tumor.The characteristics and onset interval were just similar to those described in the literature,in which the mechanisms were mentioned as common effects of tumor cell,microenviroment and therapies.This patient got effects through the initial treatment,but considering the poor outcome by former researchers,the prognosis needed to be closely followed up.Conclusion Sequential development of EBV-unrelated DLBCL after PTCL-NOS is very rare,and the mechanism,therapy and prognosis need further investigation.